Nonalcoholic fatty liver disease
Conditions
Interventions
None listed
Sponsors
Keio University, School of Medicine Division of Gastroenterology and Hepatology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients to have bariatric surgery with BMI>=32.5kg/m2 medicine treatment-refractory morbid obesity.
Exclusion criteria
Exclusion criteria: Patients with a medical history of gastric surgery or uncontrolled mental illness, drug addiction and alcohol use disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The serum cytokine profiles 12weeks after bariatric surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| The serum cytokine profiles 24 and 48weeks after bariatric surgery | — |
Countries
Japan
Contacts
Public ContactNobuhiro Nakamoto
Keio University, School of Medicine Division of Gastroenterology and Hepatology
Outcome results
None listed